Fracture risk prediction with FRAX in Slovak postmenopausal women

Central European Journal of Medicine

Volumn 8, Issue 5, 2013, Pages 571-576

  Némethová, Eva ^a   Killinger, Zdenko ^a   Payer, Juraj ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Fracture risk; FRAX; Osteoporosis; Treatment thresholds

Indexed keywords

ADULT; ARTICLE; BONE DENSITY; CLINICAL ASSESSMENT TOOL; FEMALE; FEMUR NECK; FRACTURE RISK ASSESSMENT TOOL; FRAGILITY FRACTURE; HIGH RISK PATIENT; HIP; HIP FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SLOVAKIA;

EID: 84885182085     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-013-0205-2     Document Type: Article

References (33)

1. Kanis J.A., McCloskey E.V., Johansson H., Cooper C., Rizzoli R., Reginster J.Y., et al., European guideance for the diagnosis and management of osteoporosis in postmenopausal women, Osteoporos Int, 2013, 24(1), 23-57
2. Magaziner J., Simonsick E.M., Kashner T.M., Hebel J.R., Kenzora J.E., Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study, J Gerontol, 1990, 45(3), M101-107
3. Payer J., Killinger Z., et al., Osteoporóza, Herba, Bratislava 2012
4. National Osteoporosis Foundation, Clinician's Guide to Prevention and Treatment of Osteoporosis, Washington, DC: National Osteoporosis Foundation, 2010
5. McCloskey E.V., Johansson H., Oden A., Kanis J.A., Fracture risk assesment, Clinical Biochemistry, 2012,45, 887-893
6. Kanis J.A., Hans D., Cooper C., Baim S., Bilezikian J.P., Binkley N., et al., Interpretation and use of FRAX in clinical practice. Osteoporos Int, 2011, 22, 2395-2411
7. Gehlbach S.H., Bigelow C., Heimisdottir M., May S., Walker M., Kirkwood J.R., Recognition of vertebral fracture in a clinical setting, Osteoporos Int, 2000, 11(7), 577-582
8. Hans D.B., Kanis J.A., Baim S., Bilezikian J.P., Binkley N., Cauley J.A., et al., Joint official positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX, Journal of Clinical Densitometry: Assessment of Skeletal Health, 2011, 14(3), 171-180
9. Sornay-Rendu E., Munoz F., Delmas P.D., Chapurlat RD., The FRAX tool in French women: how well does it describe the real incidence of fracture in the OFELY cohort? J Bone Miner Res, 2010, 25, 2101-2107
10. González-Macías J., Marin F., Vila J., Díez- Pérez A., Probability of fractures predicted by FRAX and observed incidence in the Spanish ECOSAP study cohort, Bone 2012, 50(1), 373-377
11. Fraser L.A., Langsetmo L., Berger C., Ioannidis G., Goltzman D., Adachi J.D., et al, Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos, Osteoporos Int, 22, 829-837
12. Tremollieres F.A., Pouillés J.M., Drewniak N., Laparra J., Ribot C.A., Fargent-Molina P., Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool, J Bone Miner Res, 2010, 25(5), 1002-1009
13. Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., What was your fracture risk evaluated by FRAX the day before your osteoporotic fracture?, Clin Rheumatol, 2013, 32(2), 219-223
14. Ensrud K.E., Lui L.Y., Taylor B.C., Schousboe J.T., Donaldson M.G., Fink H.A., et al., A comparison of prediction models for fractures in older women: is more better?, Arch Int Med, 2009, 169(22), 2087-2094
15. Donaldson M.G., Palermo L., Schousboe J.T., Ensrud K.E., Hochberg M.C., Cummings S.R., FRAX and risk of vertebral fractures: The fracture intervention trial, Journal of Bone and Mineral Research, 2009, 24(11), 1793-1799
16. Pluskiewicz W., Adamczyk P., Franek E., Leszczynski P., Sewerynek E., Wirchowska H., et al, Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility, Bone 2010,46(6),1661-1667
17. Cummins N.M., Poku E.K., Towler M.R., O'Driscoll O.M., Ralston S.H., Clinical Risk Factors for Osteoporosis in Ireland and the UK: A Comparison of FRAX and QFractureScores, Calcif Tissue Int, 2011, 89,172-177
18. Waris V.J., Sirola J.P., Kiviniemi V.V., Tuppurainen M.T., Waris V.P., Mikkeli Osteoporosis Index Identifies Fracture Risk Factors and Osteoporosis and Intervention Thresholds Parallel with FRAX, Journal of Osteoporosis, 2011, 2011, ID 732560, 7 pages doi:10.4061/2011/732560
19. McCloskey E., Johansson H., Oden A., Kanis J.A., Fracture risk assessment, Clinical Biochemistry, 2012, 46, 887-893
20. Poku E.K., Towler M.R., Cummins N.M., Newman J.D., Developing Novel Prognostic Biomarkers for Multivariate Fracture Risk Prediction Algortihms Calcif Tissue Int 2012,91,204-214
21. Collins G.S., Michaelsson K., Fracture risk assessment: state of the art, methodologically unsound, or poorly reported?, Curr Osteoporos Rep, 2012,10,199-207
22. Lippuner K., Johansson H., Borgstrom F., Kanis J.A., Rizzoli R., Cost-effective intervention thresholds against osteoporotic fractures based on FRAX in Switzerland, Osteoporosis Int, 2012, 23, 2579-2589
23. Compston J., Cooper A., Cooper C., Francis R., Kanis J.A., Marsch D., et al., Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from age of 50 years in the UK, Maturitas, 2009, 62(2), 105-108
24. Johansson H., Kanis J.A., McCloskey E.V., Oden A., Devogelaer J.-P., Kaufman J.M, et al., A FRAX model for the assessment of fracture probability in Belgium, Osteoporosis Int, 2011, 22, 453-461
25. Fujiwara S., Nakamura T., Orimo H., Hosoi T., Gorai I., Oden A., et al., Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX), Osteoporosis Int, 2008, 19, 429-435
26. Socialstyrelsen, rörelseorganens sjukdomar 2012 Osteoporos, artros, inflammatorisk ryggsjukdom och ankyloserande spondylit, psoriasisartrit och reumatoid artrit Stöd för styrning och ledning. Socialstyrelsen/Iwa Wasberg, 2012
27. Braun J., Pfeilschifter J., Leitliniengerechte Diagnostik und Therapie der Osteoporose 2010, Z Rheumatol, 2010, 69, 327-339
28. Lorenc R., G'uszko P., Karczmarewicz E., Ksiȩżopolska- Orłowska K., Misiorowski W., Franek E., et al., Recommendations on the diagnosis and treatment of osteoporosis. Reducing the incidence of fractures through effective prevention and treatment., Terapia, 2007, XV,9, 3-51
29. Leslie W.D., Lix L.M., Langsetmo L., Berger C., Goltzman D., Hanley D.A., et al. Construction of a FRAX model for the assessment of fracture probability in Canada and implications for treatment, Osteoporosis Int, 2011,22,817-827
30. Kanis J.A., Borgstrom F., De Laet C., Johansson H., Johnell O., Jonsson B., et al., Assessment of fracture risk, Osteoporos Int, 2005, 16, 581-589
31. Bruyére O., Fossi M., Zegels B., Leonori L., Hilingsmann M. Neuprez A., Reginster J.Y., Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria, Rheumatol Int, (in press), DOI: 10.1007/s00296-012-2460-y
32. Crabtree N.J., Bebbington N.A., Chapman D.M., Wahid Y.S., Ayukt J., Boivin C.M., et al., Impact of UK National Guidelines based on FRAX - comparison with current clinical practice, Clinical Endocrinology, 2010, 73, 452-456
33. Bolland M.J., Grey A., Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines, J Clin Endocrinol Metab, 2010, 95, 1856-1860